Programmed cell death 1 inhibitor alone or combined with chemotherapy for patients with locally advanced or metastatic urothelial carcinoma: a single-center experience

Programmed cell death 1 inhibitor alone or combined with chemotherapy for patients with locally advanced or metastatic urothelial carcinoma: a single-center experience

Abstract Background Immune checkpoint inhibitors (ICIs) alone or in combination with standard chemotherapy for advanced urothelial carcinoma (UC) have been tested as first-line treatment in clinical trials. This study aimed to evaluate the clinical outcomes of programmed cell death 1 (PD-1) inhibito...

Full description

Saved in:
Bibliographic Details
Main Authors: Xing Huang, Chupeng Sun, Peng Zhang, Lei Wang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Urology
Subjects:
Programmed cell death 1
Chemotherapy
Efficacy
Prognosis
Urothelial carcinoma
Online Access:https://doi.org/10.1186/s12894-024-01674-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items